169 related articles for article (PubMed ID: 9030567)
1. Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
Avidor-Reiss T; Nevo I; Saya D; Bayewitch M; Vogel Z
J Biol Chem; 1997 Feb; 272(8):5040-7. PubMed ID: 9030567
[TBL] [Abstract][Full Text] [Related]
2. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Heldman E; Vogel Z
Mol Pharmacol; 1998 Aug; 54(2):419-26. PubMed ID: 9687584
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Vogel Z
Neuropharmacology; 2000 Jan; 39(3):364-71. PubMed ID: 10698002
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.
Steiner D; Avidor-Reiss T; Schallmach E; Saya D; Vogel Z
J Mol Neurosci; 2005; 27(2):195-203. PubMed ID: 16186630
[TBL] [Abstract][Full Text] [Related]
5. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor.
Rhee MH; Nevo I; Avidor-Reiss T; Levy R; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):746-52. PubMed ID: 10727521
[TBL] [Abstract][Full Text] [Related]
6. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.
Schallmach E; Steiner D; Vogel Z
J Mol Neurosci; 2006; 29(2):115-22. PubMed ID: 16954601
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.
Rhee MH; Bayewitch M; Avidor-Reiss T; Levy R; Vogel Z
J Neurochem; 1998 Oct; 71(4):1525-34. PubMed ID: 9751186
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.
Steiner D; Avidor-Reiss T; Schallmach E; Butovsky E; Lev N; Vogel Z
Biochem J; 2005 Mar; 386(Pt 2):341-8. PubMed ID: 15537392
[TBL] [Abstract][Full Text] [Related]
10. Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.
Eckhardt K; Nevo I; Levy R; Mikus G; Eichelbaum M; Vogel Z
FEBS Lett; 2000 Mar; 470(3):309-14. PubMed ID: 10745087
[TBL] [Abstract][Full Text] [Related]
11. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adenylyl cyclases in cultured human granulosa cells.
Asbóth G; Price SA; Bellinger J; Ledger W; Barlow DH; Bernal AL
Reproduction; 2001 Feb; 121(2):217-28. PubMed ID: 11226046
[TBL] [Abstract][Full Text] [Related]
13. Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation.
Bayewitch ML; Nevo I; Avidor-Reiss T; Levy R; Simonds WF; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):820-5. PubMed ID: 10727531
[TBL] [Abstract][Full Text] [Related]
14. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of AGS3 during morphine withdrawal promotes cAMP superactivation via adenylyl cyclase 5 and 7 in rat nucleus accumbens/striatal neurons.
Fan P; Jiang Z; Diamond I; Yao L
Mol Pharmacol; 2009 Sep; 76(3):526-33. PubMed ID: 19549762
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation.
Varga EV; Rubenzik M; Grife V; Sugiyama M; Stropova D; Roeske WR; Yamamura HI
Eur J Pharmacol; 2002 Sep; 451(1):101-2. PubMed ID: 12223234
[TBL] [Abstract][Full Text] [Related]
17. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
18. Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization.
Zhao H; Loh HH; Law PY
Mol Pharmacol; 2006 Apr; 69(4):1421-32. PubMed ID: 16415176
[TBL] [Abstract][Full Text] [Related]
19. Adenylate cyclases in keratinocytes: FRSK cells express types I, II, III, IV, VI and VIII, and 1,25(OH)2D3, retinoic acid and TPA augment forskolin-induced cyclic AMP accumulation in the absence of altered isozyme expression.
Takahashi H; Kinouchi M; Tamura T; Ishida-Yamamoto A; Iizuka H
Arch Dermatol Res; 1998 Aug; 290(8):407-12. PubMed ID: 9763301
[TBL] [Abstract][Full Text] [Related]
20. Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure.
Espinasse I; Iourgenko V; Richer C; Heimburger M; Defer N; Bourin MC; Samson F; Pussard E; Giudicelli JF; Michel JB; Hanoune J; Mercadier JJ
Cardiovasc Res; 1999 Apr; 42(1):87-98. PubMed ID: 10434999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
